Rebound growth of infantile hemangiomas after propranolol therapy
SD Shah, E Baselga, C McCuaig, E Pope, J Coulie… - …, 2016 - publications.aap.org
METHODS: A multicenter retrospective cohort study was conducted in patients with IHs
treated with propranolol. Patient demographic characteristics, IH characteristics, and
specifics of propranolol therapy were obtained. Episodes of rebound growth were recorded.
Patients' responses to propranolol were evaluated through a visual analog scale. RESULTS:
A total of 997 patients were enrolled. The incidence of rebound growth was 231 of 912
patients (25.3%). Mean age at initial rebound was 17.1 months. The odds of rebound among …
treated with propranolol. Patient demographic characteristics, IH characteristics, and
specifics of propranolol therapy were obtained. Episodes of rebound growth were recorded.
Patients' responses to propranolol were evaluated through a visual analog scale. RESULTS:
A total of 997 patients were enrolled. The incidence of rebound growth was 231 of 912
patients (25.3%). Mean age at initial rebound was 17.1 months. The odds of rebound among …